ЛУБЕР Джозеф Р. (US),САУДЕН Гарри С. (US),БАНИК Фрэнк Дж. (US),КРИКСУНОВ Лео Б. (US),УИНН Дэвид В. (US),ШИМЧАК Кристофер И. (US)
申请号：
RU2012116335/15
公开号：
RU2012116335A
申请日:
2010.09.23
申请国别(地区):
RU
年份:
2013
代理人:
摘要：
1. A tablet containing one or more pharmaceutically active substances, one or more thickeners and one or more binders, said tablet containing at least 200 mg of said pharmaceutically active substance (s), and said tablet is fused with said ( i) binding agent (s) in such a way that said tablet (i) is soaked in water in less than 60 seconds and (ii) breaks down under conditions in more than 60 seconds. 2. A tablet according to claim 1, wherein the time for soaking said tablet with water is less than 30 seconds. A tablet according to claim 1, wherein the destruction time of said tablet under conditions is more than 180 seconds. A tablet according to claim 1, containing at least 5% by weight. the specified binder (s) of the substance (s) .5. A tablet according to claim 1, wherein said binding agent (s) (s) is (are) a binder melted by RF radiation with a melting point of from about 40 ° C to about 140 ° C. A tablet according to claim 1, comprising a polyethylene glycol binder. 7. A tablet according to claim 1, wherein said binder is a water-activated binder. A tablet according to claim 1, containing at least 50% by weight. of the indicated pharmaceutically active substance (s) .9. A tablet according to claim 1, containing a pharmaceutically active substance selected from ibuprofen, acetaminophen, antacids, vitamin, metformin and their pharmaceutically acceptable salts. A tablet according to claim 1, containing a polyethylene oxide thickener. 11. A tablet according to claim 1, containing less than 10 percent weight. carbohydrates. 12. Method for administering one or more pharmaceutically active substances1. Таблетка, содержащая одно или несколько фармацевтически активных веществ, один или несколько загустителей и одно или несколько связующих веществ, причем указанная таблетка содержит по меньшей мере 200 мг указанного фармацевтически активного(ых) вещества (веществ), и указанную таблетку сплавляли с указанным(и) связующим(и) веществом(ами) таким образом, что указанная таб
